Clotting Factor-FC Chimeric Proteins to Treat Hemophilia
Details for Australian Patent Application No. 2010201711 (hide)
International Classifications
Event Publications
13 May 2010 Complete Application Filed
20 May 2010 Application Open to Public Inspection
Published as AU-B-2010201711
26 August 2010 Section 223 Application Allowed
Syntonix Pharmaceuticals, Inc. The time in which to make a further application for a divisional patent has been extended to 28 May 2010. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000
5 April 2012 Application Accepted
Published as AU-B-2010201711
19 July 2012 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 13 Jun 2012 . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010201712-2'-substituted oligomeric compounds and compositions for use in gene modulations
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser